Putative Drug Target Identification in Tinea Causing Pathogen Trichophyton rubrum Using Subtractive Proteomics

Mohamed Hussain Syed Abuthakir1, Thomas Jebastin2, Velusamy Sharmila1

  • 1Biochematics Laboratory, Department of Bioinformatics, Bharathiar University, Coimbatore, Tamil Nadu, 641 046, India.

Current Microbiology
|July 19, 2020
PubMed

Insights

Researchers identified two novel drug targets in Trichophyton rubrum, a fungus causing skin infections. This study focused on finding targets unique to the fungus, avoiding human or gut bacteria proteins, to develop safer antifungal drugs.

Area of Science:

  • Mycology
  • Proteomics
  • Drug Discovery

Background:

  • Dermatophytes, such as Trichophyton, cause superficial fungal infections in skin, nails, and hair.
  • Current antifungal drugs have side effects, driving the need for novel therapeutic targets.
  • Trichophyton rubrum is a significant dermatophyte responsible for common human infections.

Purpose of the Study:

  • To identify novel drug targets in Trichophyton rubrum using subtractive proteomics.
  • To find proteins essential for T. rubrum but absent in humans and their gut microbiota.
  • To analyze the druggability and pathways of potential drug targets.

Main Methods:

  • Subtractive proteomics approach analyzing the whole proteome of T. rubrum.
  • Identification of proteins non-homologous to human proteins and human gut flora.
  • Analysis of sub-cellular localization, functional classification, protein networks, and druggability.
  • Inclusion of pathogen domain non-homology to human domains and gut microbiota.

Main Results:

  • Identification of two novel drug targets specific to T. rubrum.
  • These targets are absent in both human proteomes and human gut microbiota.
  • Analysis confirmed the essentiality and druggability of the identified targets.

Conclusions:

  • The study successfully identified two unique drug targets for T. rubrum.
  • These targets represent promising candidates for developing safer and more effective antifungal therapies.
  • The subtractive proteomics approach, with added validation steps, is effective for dermatophyte drug discovery.

Related Concept Videos